|
000
| 01574cam 2200349zi 4500 |
|---|
| 001 | 9.898406 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107174831 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 210408t20212021onc ob f00| 0 eng d |
|---|
| 020 | |a9780660383248 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH164-317/2021E-PDF |
|---|
| 245 | 00|aGuidance on evaluation fees for human drugs and disinfectants. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2021. |
|---|
| 264 | 4|c©2021 |
|---|
| 300 | |a1 online resource (ii, 17 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Lignes directrices sur les frais d’évaluation des médicaments à usage humain et des désinfectants assimilés à une drogue. |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (page 17). |
|---|
| 650 | 0|aDrug approval|zCanada. |
|---|
| 650 | 0|aFees, Administrative|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tLignes directrices sur les frais d’évaluation des médicaments à usage humain et des désinfectants assimilés à une drogue.|w(CaOODSP)9.898408 |
|---|
| 856 | 40|qPDF|s863 KB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H164-317-2021-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fees/fees-review-drug-submissions-applications.html |
|---|